Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802

BRIEF-Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802

- Jubilant Pharmova Ltd JUBA.NS:

  • JUBILANT PHARMOVA - JUBILANT THERAPEUTICS ANNOUNCES ORAL PRESENTATION OF PRELIMINARY PHASE 1 CLINICAL DATA FOR JBI-802

  • JUBILANT PHARMOVA - ABSTRACT DATA SHOW RAPID PLATELET REDUCTIONS AND DURABLE HEMATOLOGIC CONTROL

Source text: ID:nBSE2PCcZV

Further company coverage: JUBA.NS


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Jubilant Pharmova

See all news